2nd Published 30dy FRN

1949

Federal Register / Vol. 81, No. 9 / Thursday, January 14, 2016 / Notices
The firm’s Method 1 score is the sum of
its weighted systemic indicator scores.
The GSIB surcharge for the firm is then
the higher of the GSIB surcharge
determined under Method 1 and a
second method that weights size,
interconnectedness, cross-jurisdictional
activity, complexity, and reliance on
wholesale funding (instead of
substitutability).2
The aggregate global indicator
amounts used in the score calculation

under Method 1 are based on data
collected by the Basel Committee on
Banking Supervision (BCBS). The BCBS
amounts are determined based on the
sum of the systemic indicator scores of
the 75 largest U.S. and foreign banking
organizations as measured by the BCBS,
and any other banking organization that
the BCBS includes in its sample total for
that year. The BCBS publicly releases
these values in euros each year. To
account for changes in currency values,

the GSIB surcharge rule indicates that
the Board will publish the aggregate
global indicator amounts each year in
U.S. dollars.3
The aggregate global indicator
amounts for purposes of the Method 1
score calculation under the GSIB
surcharge rule for 2015, which were
calculated as part of the end-2014 GSIB
assessment, are:

AGGREGATE GLOBAL INDICATOR AMOUNTS IN U.S. DOLLARS (USD) FOR 2015
Systemic indicator

Size ...................................................
Interconnectedness ...........................

Total exposures ..........................................................................................
Intra-financial system assets ......................................................................
Intra-financial system liabilities ..................................................................
Securities outstanding ................................................................................
Payments activity .......................................................................................
Assets under custody .................................................................................
Underwritten transactions in debt and equity markets ..............................
Notional amount of over-the-counter (OTC) derivatives ............................
Trading and available-for-sale (AFS) securities ........................................
Level 3 assets ............................................................................................
Cross-jurisdictional claims ..........................................................................
Cross-jurisdictional liabilities ......................................................................

Substitutability/financial institution infrastructure.
Complexity ........................................
Cross-jurisdictional activity ...............

Authority: 12 U.S.C. 248(a), 321–338a,
481–486, 1462a, 1467a, 1818, 1828, 1831n,
1831o, 1831p–l, 1831w, 1835, 1844(b), 1851,
3904, 3906–3909, 4808, 5365, 5368, 5371.
By order of the Board of Governors of the
Federal Reserve System, January 11, 2016.
Robert deV. Frierson,
Secretary of the Board.
[FR Doc. 2016–00589 Filed 1–13–16; 8:45 am]
BILLING CODE 6210–01–P

FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies

mstockstill on DSK4VPTVN1PROD with NOTICES

Aggregate global
indicator amount in USD
(end-2014 assessment)

Category

The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
2 The second method (Method 2) uses similar
inputs to those used in Method 1, but replaces the
substitutability category with a measure of a firm’s

VerDate Sep<11>2014

16:39 Jan 13, 2016

Jkt 238001

inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than February 8,
2016.
A. Federal Reserve Bank of Boston
(Prabal Chakrabarti, Senior Vice
President) 600 Atlantic Avenue, Boston,
Massachusetts 02210–2204, or
BOS.SRC.Applications.Comments@
bos.frb.org:
1. Spencer MHC, and Spencer MidTier Holding Company, both in Spencer,
Massachusetts; to merge with Green
Valley Bancorp, MHC, and Green Valley
Bancorp, Inc., and thereby indirectly
acquire voting shares of Southbridge
use of short-term wholesale funding. In addition,
Method 2 is calibrated differently from Method 1.

PO 00000

Frm 00013

Fmt 4703

Sfmt 4703

89,657,702,623,292
9,553,265,287,432
10,766,503,932,080
14,829,559,920,658
2,588,833,244,898,340
141,055,159,810,929
6,457,421,866,621
773,613,780,418,221
3,983,442,843,602
799,000,645,785
20,924,671,362,004
19,029,188,523,805

Savings Bank, all in Southbridge,
Massachusetts.
Board of Governors of the Federal Reserve
System, January 11, 2016.
Michael J. Lewandowski,
Associate Secretary of the Board.
[FR Doc. 2016–00599 Filed 1–13–16; 8:45 am]
BILLING CODE 6210–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–16–15BM]

Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
3 12 CFR 217.404(b)(1)(i)(B); 80 FR 49082, 49086–
87 (August 14, 2015).

E:\FR\FM\14JAN1.SGM

14JAN1

1950

Federal Register / Vol. 81, No. 9 / Thursday, January 14, 2016 / Notices

information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to [email protected]. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Assessing the Impact of
Organizational and Personal
Antecedents on Proactive Health/Safety
Decision Making—New—National
Institute for Occupational Safety and
Health (NIOSH), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
NIOSH, under Public Law 91–596,
Sections 20 and 22 (Section 20–22,
Occupational Safety and Health Act of
1977) has the responsibility to conduct
research relating to innovative methods,
techniques, and approaches dealing
with occupational safety and health
problems.

This research relates to the interplay
of personal, organizational, and cultural
influences on risk-taking and proactive
decision-making behaviors among mine
workers. The antecedents, or
characteristics, that impact these
behaviors are not well understood in
mining. Understanding the degree to
which antecedents influence decisions
can inform the focus of future health
and safety management interventions.
NIOSH proposes a project that seeks
to empirically understand the following:
What are the most important
organizational antecedent
characteristics needed to support
worker health and safety (H&S)
performance behaviors in the mining
industry?
What are the most important personal
antecedent characteristics needed to
support worker health and safety (H&S)
performance behaviors in the mining
industry?
To answer the above questions,
NIOSH researchers developed a
psychometrically supported survey.
Researchers identified seven worker
perception-based ‘organizational values’
and four ‘personal characteristics’ that
are presumed to be important in
fostering H&S knowledge, motivation,
proactive behaviors, and safety
outcomes. Because these emergent,
worker perception-based constructs
have a theoretical and empirical history,
psychometrically tested items exist for
each of them.
NIOSH researchers will administer
this survey at mine sites to as many
participating mine workers as possible
to answer the research questions. Upon
data collection and analysis NIOSH
researchers will revalidate each scale to
ensure that measurement is valid. A
quantitative approach, via a short
survey, allows for prioritization, based
on statistical significance, of the
antecedents that have the most critical
influence on proactive behaviors. Data
collection will take place with
approximately 1800 mine workers over
three years. The respondents targeted
for this study include any active mine
worker at a mine site, both surface and
underground. All participants will be

between the ages of 18 and 75, currently
employed, and living in the United
States. Participation will require no
more than 20 minutes of workers’ time
(5 minutes for consent and 15 minutes
for the survey). There is no cost to
respondents other than their time.
Upon collection of the data, it will be
used to answer what organizational/
personal characteristics have the biggest
impact on proactive and compliant
health and safety behaviors. Dominance
and relative weights analysis will be
used as the data analysis method to
statistically rank order the importance
of predictors in numerous regression
contexts. Safety proactive and safety
compliance will serve as the dependent
variables in these regression analyses,
with the organizational and personal
characteristics as independent variables.
Findings will be used to improve the
safety and health organizational values
and focus of mine organizations, as
executed through their health and safety
management system for mitigating
health and safety risks at their mine site.
Specifically, if organizations are lacking
in values that are of high importance
among employees, site leadership
knows where to focus new, innovative
methods, techniques, and approaches to
dealing with their occupational safety
and health problems. Finally, the data
can be directly compared to data from
other mine organizations that
administered the same standardized
methods to provide broader context for
areas in which the mining industry can
focus more attention if trying to
encourage safer work behavior.
An estimated sample of up to 1,800
mine employees will be collected from
various mining operations which have
agreed to participate. In order to reach
a sample of 1,800, researchers will try
to secure participation from
approximately twenty-one mine
operations. It is estimated that it will
take about 5 minutes to recruit a
particular mine and 5 minutes to
consent the individual workers. The
amount of time to complete the survey
data collection instrument is about 15
minutes. There is no cost to respondents
other than there time.

mstockstill on DSK4VPTVN1PROD with NOTICES

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Type of respondent

Form name

Safety/health Mine Operator ...........................
Mine Worker ....................................................
Mine Worker ....................................................

Mine Recruitment Script .................................
Individual Miner Recruitment Script ...............
Survey ............................................................

VerDate Sep<11>2014

16:39 Jan 13, 2016

Jkt 238001

PO 00000

Frm 00014

Fmt 4703

Sfmt 4703

E:\FR\FM\14JAN1.SGM

7
600
600

14JAN1

Number of
responses per
respondent
1
1
1

Average
burden per
response
(in hours)
5/60
5/60
15/60

Federal Register / Vol. 81, No. 9 / Thursday, January 14, 2016 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–00562 Filed 1–13–16; 8:45 am]
BILLING CODE 4163–18–P

Proposed Project
Prevent Hepatitis Transmission
among Persons Who Inject Drugs—
New—National Center for HIV/AIDS,
Viral Hepatitis, STD, and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–16–15ARG]

mstockstill on DSK4VPTVN1PROD with NOTICES

Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or

VerDate Sep<11>2014

16:39 Jan 13, 2016

Jkt 238001

send an email to [email protected]. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, Washington, DC 20503 or by fax
to (202) 395–5806. Written comments
should be received within 30 days of
this notice.

Background and Brief Description
Hepatitis C virus (HCV) infection is
the most common chronic blood borne
infection in the United States;
approximately three million persons are
chronically infected. Identifying and
reaching persons at risk for HCV
infection is critical to prevent
transmission and treat and cure if
infected. CDC monitors the national
incidence of acute hepatitis C through
passive surveillance of acute,
symptomatic cases of laboratory
confirmed hepatitis C cases. Since 2006,
surveillance data have shown a trend
toward reemergence of HCV infection
mainly among young persons who inject
drugs (PWID) in nonurban counties. Of
the cases reported in 2013 with
information on risk factors 62%
indicated injection drug use as the
primary risk for acute hepatitis C. The
prevention of HCV infection among
PWIDs requires an integrated approach
including harm reduction interventions,
substance abuse treatment, and
prevention of other blood borne
infections, and care and treatment of
HCV infection.
The purpose of the proposed study is
to address the high prevalence of HCV
infection by developing and
implementing an integrated approach
for detection, prevention, care and
treatment of infection among persons
aged 18–30 years who reside in nonurban counties. Awardees will develop
and implement a comprehensive
strategy to enroll young non-urban
PWID, collect epidemiological
information, test for viral hepatitis and
HIV infection and provide linkage to
primary care services, prevention

PO 00000

Frm 00015

Fmt 4703

Sfmt 4703

1951

interventions, and treatment for
substance abuse and HCV infection. In
addition to providing HCV testing,
participants will be offered testing for
the presence of co-infections with
hepatitis B virus (HBV) and HIV.
Adherence to prevention services and
retention in care will be assessed
through follow up interviews.
Furthermore, re-infection with HCV will
be evaluated through follow-up blood
tests.
The project will recruit an estimated
total of 995 young PWIDs to enroll 895
PWIDs. The participants will be
recruited from settings where young
PWIDs obtain access to care and
treatment services. Recruitment will be
direct and in-person by partnering with
local harm reduction sites. Recruiters
will enroll subjects across recruitment
sites primarily through drug treatment
programs and syringe exchange
programs, as well as persons referred to
these sites as a result of referral from
other programs and respondent driven
sampling. Those who consent to
participate will be administered an
eligibility interview questionnaire by
trained field staff. If found eligible, the
participant will take an intervieweradministered survey that includes
information on initiation of drug use,
injection practices, HCV, HBV and HIV
infection status, access to prevention
and medical care, desire to receive and
barriers to receiving HCV treatment, and
missed opportunities for hepatitis
prevention. Participants will receive
counselling regarding adherence to
medical and/or drug treatment services
and prevention services. Participants
will be interviewed for a maximum of
5 times within any 12-month interval
during the course of the study: consent
and interview at enrollment/baseline for
an estimated 60 minutes, and 30-minute
follow-up interviews every 3 months
thereafter. Participants will be
interviewed throughout the study
during the 3-year project. However,
most of the recruitment will be spread
over first two years to allow for one year
follow up period of the later recruits.
Participation in interviews and
responses to all study questions are
totally voluntary and there is no cost to
respondents other than their time. The
annualized burden to participants is 974
hours.

E:\FR\FM\14JAN1.SGM

14JAN1